GL1X · GenesisL1 explorer

Research workbench

Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with tipranavir

Analyse Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4NJU
Type
protein
Length
396 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
UniProt
Q9J006
Ligands
TPV
Pockets
2 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 57% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, DProteaseprotein997% helix, 57% strandQ9J006

Ligands and binding sites

  • TPV · N-(3-{(1R)-1-[(6R)-4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)-5-(trifluoromethyl)-2-pyridinesulfonamide · ligand · 2 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13160.720.8438TPV
23200.710.8433TPV

Interfaces

5 interfaces between chains.

  • A–B · 1901 Ų buried · 35 hydrogen bonds · protein-protein
  • C–D · 1888 Ų buried · 36 hydrogen bonds · protein-protein
  • A–D · 20 Ų buried · 0 hydrogen bonds · protein-protein
  • B–C · 18 Ų buried · 0 hydrogen bonds · protein-protein
  • A–C · 12 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 4NJU · Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.